X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (125) 125
oncology (119) 119
female (113) 113
index medicus (112) 112
breast cancer (103) 103
cancer (64) 64
prognosis (62) 62
breast neoplasms - genetics (51) 51
breast neoplasms - pathology (49) 49
breast neoplasms - drug therapy (47) 47
middle aged (42) 42
chemotherapy (41) 41
tumors (41) 41
adult (35) 35
metastasis (35) 35
trastuzumab (31) 31
aged (30) 30
immunotherapy (30) 30
gene expression (29) 29
mutation (29) 29
tumor-infiltrating lymphocytes (29) 29
animals (26) 26
antineoplastic combined chemotherapy protocols - therapeutic use (26) 26
breast neoplasms - immunology (25) 25
expression (25) 25
lymphocytes (25) 25
research (25) 25
breast neoplasms - metabolism (24) 24
care and treatment (24) 24
gene expression profiling (24) 24
survival (24) 24
therapy (24) 24
disease-free survival (23) 23
genetic aspects (23) 23
breast neoplasms - mortality (20) 20
receptor, erbb-2 - metabolism (20) 20
treatment outcome (20) 20
health aspects (18) 18
mice (18) 18
resistance (18) 18
antineoplastic agents - therapeutic use (17) 17
tamoxifen (17) 17
chemotherapy, adjuvant (16) 16
lymphocytes, tumor-infiltrating - immunology (16) 16
medicine (16) 16
receptor, erbb-2 - genetics (16) 16
receptors, estrogen - metabolism (16) 16
clinical trials (15) 15
erbb-2 protein (15) 15
gene expression regulation, neoplastic (15) 15
predictive value of tests (15) 15
analysis (14) 14
biomarkers (14) 14
cell line, tumor (14) 14
neoadjuvant chemotherapy (14) 14
patients (14) 14
skin and connective tissue diseases (14) 14
article (13) 13
biomarkers, tumor - genetics (13) 13
breast neoplasms - therapy (13) 13
combination (13) 13
endocrine therapy (13) 13
estrogen (13) 13
hematology, oncology and palliative medicine (13) 13
medical research (13) 13
mutations (13) 13
biomarkers, tumor - analysis (12) 12
metastases (12) 12
multicenter (12) 12
neoplasm metastasis (12) 12
proportional hazards models (12) 12
receptor, erbb-2 - antagonists & inhibitors (12) 12
research article (12) 12
retrospective studies (12) 12
breast (11) 11
cancer therapies (11) 11
carcinoma (11) 11
estrogen-receptor (11) 11
genomics (11) 11
immunohistochemistry (11) 11
immunology (11) 11
neoadjuvant therapy (11) 11
neoplasm staging (11) 11
pathology (11) 11
phenotype (11) 11
randomized controlled trials as topic (11) 11
survival analysis (11) 11
activation (10) 10
biochemistry (10) 10
biomarkers, tumor (10) 10
breast neoplasms - chemistry (10) 10
cells (10) 10
drug therapy (10) 10
epidermal growth factor (10) 10
her2 (10) 10
kaplan-meier estimate (10) 10
neoplasms (10) 10
open-label (10) 10
triple negative breast neoplasms - pathology (10) 10
beer (9) 9
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Nature Medicine, ISSN 1078-8956, 10/2019, Volume 25, Issue 10, pp. 1466 - 1466
Sherene Loi is a medical oncologist and clinician scientist at the Peter MacCallum Cancer Centre in Melbourne, Australia. Her laboratory studies the cancer... 
Practice | Oncologists | Care and treatment | Breast cancer | Genetic aspects | Genomes | Immunosuppressive agents | Cancer
Journal Article
The Lancet Oncology, ISSN 1470-2045, 12/2018, Volume 19, Issue 12, pp. 1551 - 1554
Journal Article
Cancer Research, ISSN 0008-5472, 05/2015, Volume 75, Issue 9 Supplement, pp. ES6-3 - ES6-3
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 04/2015, Volume 33, Issue 11, pp. 1299 - 1300
Journal Article
Molecular Cancer Research, ISSN 1541-7786, 02/2016, Volume 14, Issue 2 Supplement, pp. IA16 - IA16
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2016, Volume 17, Issue 4, pp. 425 - 439
Journal Article
OncoImmunology, ISSN 2162-4011, 07/2013, Volume 2, Issue 7, p. e24720
By analyzing over 2000 samples from a randomized clinical trial, we have recently associated high levels of tumor-infiltrating lymphocytes with an excellent... 
immunotherapies | breast cancer | prognosis | trastuzumab efficacy | biomarkers | tumor infiltrating lymphocytes | Biomarkers | Breast cancer | Prognosis | Tumor infiltrating lymphocytes | Trastuzumab efficacy | Immunotherapies | MICROENVIRONMENT | ONCOLOGY | IMMUNOLOGY | ADJUVANT | Author's View
Journal Article
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 07/2015, Volume 373, Issue 3, pp. 209 - 219
In women with hormone-receptor–positive metastatic breast cancer that had progressed after endocrine therapy, palbociclib plus fulvestrant was associated with... 
TARGET | MEDICINE, GENERAL & INTERNAL | THERAPY | FULVESTRANT | CLINICAL-TRIALS | CYCLIN D | RESISTANCE | MUTATIONS | COMBINATION | ESTROGEN-RECEPTOR | 4/6 INHIBITOR PALBOCICLIB | Cyclin-Dependent Kinase 6 - antagonists & inhibitors | Estradiol - analogs & derivatives | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Receptors, Estrogen - analysis | Protein Kinase Inhibitors - adverse effects | Receptors, Progesterone - analysis | Pyridines - adverse effects | Aged, 80 and over | Estradiol - adverse effects | Adult | Female | Cyclin-Dependent Kinase 4 - antagonists & inhibitors | Pyridines - therapeutic use | Double-Blind Method | Estradiol - therapeutic use | Biomarkers - analysis | Piperazines - therapeutic use | Breast Neoplasms - drug therapy | Piperazines - adverse effects | Disease-Free Survival | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Protein Kinase Inhibitors - therapeutic use | Aged | Receptor, ErbB-2 - analysis | Women | Hormone receptors | Care and treatment | Usage | Breast cancer | Diagnosis | Health aspects | Thrombocytopenia | Leukopenia | Endocrine therapy | Fatigue | Metastasis | Cancer therapies | Cyclin-dependent kinase 4 | Fulvestrant | Metastases | Epidermal growth factor | Womens health | S phase | Cell cycle | Neutropenia | G1 phase
Journal Article
The Lancet Oncology, ISSN 1470-2045, 01/2018, Volume 19, Issue 1, pp. 3 - 5
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 11/2018, Volume 379, Issue 22, pp. 2108 - 2121
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 03/2013, Volume 31, Issue 7, pp. 860 - 867
Journal Article
Nature Reviews Clinical Oncology, ISSN 1759-4774, 12/2015, Volume 12, Issue 12, pp. 693 - 704
Journal Article
Journal Article